Vise Technologies, Inc. - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 204 filers reported holding PTC THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
Vise Technologies, Inc. ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$239,070
-34.6%
10,668
+18.6%
0.06%
-33.7%
Q2 2023$365,827
-11.4%
8,995
+5.6%
0.09%
-18.3%
Q1 2023$412,806
+33.9%
8,522
+5.5%
0.11%
+12.4%
Q4 2022$308,337
-9.3%
8,078
+19.3%
0.10%
-24.2%
Q3 2022$340,0006,7720.13%
Other shareholders
PTC THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,750,000$84,053,0007.32%
RTW INVESTMENTS, LP 3,832,480$184,074,0006.94%
Burrage Capital Management LLC 195,725$9,401,0006.30%
Asymmetry Capital Management, L.P. 55,408$2,661,0004.77%
SECTORAL ASSET MANAGEMENT INC 328,738$15,789,0002.36%
ARMISTICE CAPITAL, LLC 758,000$36,407,0002.10%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 114,000$5,470,0001.97%
Opaleye Management Inc. 191,000$9,174,0001.80%
Sofinnova Investments, Inc. 517,092$24,836,0001.79%
Chubb Ltd 8,180$393,0001.68%
View complete list of PTC THERAPEUTICS INC shareholders